Tags » Hemophilia A

FDA approves modified antihemophilic factor for hemophilia A

November 13, 2015

The U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. 358 more words

Hemophilia

FDA Approves Octapharma’s NUWIQ® for the Treatment of Adults and Children with Hemophilia A

14.09.2015

HOBOKEN, N.J. September 15th, 2015: Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved NUWIQ®, Antihemophilic Factor (Recombinant), an intravenous therapy for adults and children living with Hemophilia A. 1,124 more words

Hemophilia

First factor VIIIa-mimetic bispecific antibody to be investigated for the prophylactic treatment of hemophilia A

U.S. FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine ACE910 for People With Hemophilia A With Factor VIII Inhibitors

Ninth breakthrough therapy designation for Genentech’s portfolio of medicines… 745 more words

Hemophilia

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases

Sufferers of hemophilia live in a perpetual state of stress and anxiety: their joints wear down prematurely and they have bleeding episodes that feel like they will never end.  426 more words

NEWS

Hemophilia therapies drive outpatient pharmacy costs for publicly insured children

Swenson SM, et al. JAMA. 2015;doi:10.1001/jama.2015.7169.

July 29, 2015  From: HemOncToday

Medications for the treatment of hemophilia are a considerable driver of outpatient pharmacy expenditures for publicly insured children with serious chronic conditions, according to study results. 428 more words

Hemophilia

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

Published on July 24, 2015 at 7:10 AM  from News-Medical.net

For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases… 461 more words

Hemophilia

Ethanol locks reduce central venous catheter-associated bloodstream infections in children with cancer

Hemophilia patients with a port-a-cath typically use Heparin to “lock” at the end of the infusion.  The following article give an alternative to Heparin for patients with bloodstream infections. 536 more words

Hemophilia